Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agree with the other posters — this is awesome!
Exciting times here; it really feels like we are on the cusp of something big.
Great news! Nice to see revenue numbers coming in pretty much immediately after the partnership with Covetrus. This is getting exciting
Yeah I think getting some revenue projections will hopefully go a long way. It also doesn’t help that Covetrus is no longer public so there wasn’t attention in the public markets from the other side of the deal that drew investors over to ALRT.
Important to remember at times like this that sooner or later price catches up with value. Signing this deal was a momentous occasion in terms of creating shareholder value. And I think we’ll see that translate to price over time. Imagine if someone had told us a few years ago that we would be signing a distribution agreement with a multi-billion dollar company? We would’ve been over the moon. But perhaps most importantly, this deal execution gives some serious credence to the other plans / goals that the company has publicly stated.
Great news. Very excited to see a deal announced. Working with Covetrus should give ALRT plenty of credibility. The future is looking bright!
I think LastOne already answered this, but these are not new shares or options. Simply the conversion from ALRT to ALRTF for the beneficial holders.
It’s pretty crazy to see how quickly this thing can fly. Very thinly traded and maybe even more so now with the ticker change to ALRTF. It’s not every day you get a 348% increase off 54k in volume. Pretty encouraging to think what could happen when we finally get a major announcement and a large spike in buying volume.
My two cents:
The update today along with the recent insider funding of approx. $1.75M USD on a royalty-based repayment plan gives me plenty of confidence that the product launch is indeed near. They’ve put their money where their mouth is so I don’t think these are empty words in the PRs.
That said, there’s no denying that it’s frustrating when timelines get pushed back. I’m very bullish that the wait will be worth it but it’s a wait nonetheless. Good luck to everyone.
Insiders investing more money that will only generate them returns upon a successful product launch is a bullish signal IMO.
Your “going down with the ship” metaphor doesn’t make a whole lot of sense because there’s no reason they HAD to provide that large of a financing arrangement. They don’t have distribution in place yet so why structure the repayment around sales royalties if they don’t believe the product is nearing commercialization?
It seems clear that management / insiders are very confident and they are putting their money where their mouth is which is encouraging.
The delays are frustrating but I personally don’t think it’s any ominous sign. The financing deal earlier this month makes me a lot more comfortable.
The CEO’s wife is a “director and significant shareholder” of the firm that is providing the ~$1.75M USD in funding. She is also a director of ALRT (Source: 8-K filing on 9/8)
The repayment terms are tied to the success of the GluCurve product. I don’t think company insiders would willingly risk that much additional capital investment if this wasn’t a “sure thing” (in their minds) at this point.
I’m eagerly awaiting further news, but I’m willing to be patient after they secured financing. And I think anyone who gets impatient and bails will end up kicking themselves in the not-too-distant future.
Agreed. Very excited for what the (near) future has in store.
The company has pretty much telegraphed its upcoming moves lately with PR’s and other investor communications (such as the letter to shareholders or the updated investor deck) and yet still people are missing this.
This all sounds very promising. Exciting times!
Hard thing to predict. But having a clear pathway to revenue would be a major milestone, and it’s also a milestone that’s easy to understand/appreciate for outsiders who don’t know anything about ALRT yet. Hoping this will be what takes us to the next level. Not sure what that “level” is from a PPS perspective.
I’m eager for another update, and ideally the announcement of a partner for the pet diabetes solution, but it’s not like it’s been radio silence for months or anything. We did get the update about the non-inferiority study results in March, and that’s a meaningful milestone towards bringing this to market IMO. I remain optimistic on the pet health side. But time will tell. Good luck to you however you decide to proceed, but me personally I will continue to hold.
4500 shares at .046… a whopping $200 transaction. Who the hell cares? This is just pointless FUD and/or complaining. Either that or someone with a complete lack of understanding of the fluctuations you see on a low volume, low float stock.
And no surprise you don’t come back to mention the 20,000 shares that traded at .059 afterwards (and the current last price). But I suppose that’s how it goes when you look at everything through brown-colored glasses.
I’ve been pleasantly surprised as well. Volume has mostly dried back up, but nice to see it hold some gains for a few days (and hopefully longer!)
The 600k bid at .064 I mentioned filled 100k and then they cancelled the remaining 500k bid. Point being there could still be that large buy order looming (unless they changed their minds entirely). Great action today.
Sorry, shouldn’t be double posting but also wanted to say I’m loving this PR today. Seems like huge potential.
402k buy with 600k left on the bid at .064... WOW.
They look pretty well capitalized as of 3/31/21. If they raise again that is a major failure by management imo.
Good post. Thank you in particular for your point #3 clarification, I didn’t realize that.
Thanks for the insights! I enjoy your posts.
Interesting thoughts. Do you feel your Q1 / Q2 revenue numbers are conservative? Because I can’t see the market getting that excited over that slow of growth compared to where we were before. I still think the STADA deal has big potential but wonder how long it’ll take to materialize.
Agree with this. They touted record shipments in Q4 then delivered another stinker of an ER. At some point the performance has to match the story.
Well said. I find this nugget of wisdom is one I keep thinking I’ve learned when perhaps I haven’t.
The Canadian cannabis sector (including extractors) has burned many. Thankfully my interests have primarily been elsewhere and I’ve been able to avoid major damage from MediPharm or Neptune. Despite my disappointment in both I can’t help but watch what happens next.
Good luck to you as well, my friend!
Sorry to hear about the losses but glad to hear you are faring better elsewhere. My love for this stock has likewise been drying up. I had planned on re-entering but this offering makes it clear that either they are in survival mode, they don’t care about shareholders, or both. I will still watch with some interest but not sure I’ll be buying back in.
Came here to post the same thing. A lot of loading around .059 today. Over 800k in volume is a rarity for this ticker.
They follow up that stinker of an ER with this? Wow.
Thanks for sharing. The color commentary makes for a better story than the bleak numbers. The $100m PO’s are intact and possibly in the wipes or home care product line? Plus they had $60m of the loss related to non-cash items. I think at this point Neptune is in “show me” territory. They have talked a big game but unless the stock price tumbles down further I’m not sure I like the value here yet.
Agreed on both counts. I like MediPharm’s chances at a comeback a lot better than Neptune’s especially at this point. US legalization would be big for Neptune though.
I am in awe at just how terrible this Q4 earnings report was. I was once a big fan of Cammarata but he has been stirring the pot far too much to retain my confidence. They love to create hype but unfortunately they never seem to deliver.
Thankfully I have been out of this one for a while.
Nice volume today (379k) to go with the bit of price recovery. I don’t comment on this one much anymore but I am still holding my shares.
Have to admit I was a little surprised at the number of rights that were exercised. I suppose it is a function of an exhausted base of longs, but I would’ve guessed more. I exercised mine in full for what it’s worth.
Good luck to all!
Agreed. There is a cost to be paid for rapid expansion and/or changes in organizational strategy. Neptune has had both occurring which has compounded into their terrible margins.
I don’t see why management would even pursue these $100m+ in orders if they were going to be detrimental to the bottom line, much less why Perceptive would supply a credit facility to support them. I think the margins will hopefully be greatly improved in the future.
Thanks for the summary and comments!
Man, rough quarter here. Need to take a closer look before I decide whether to average down or move on.
They announced some huge PO’s ($100m over next 2 quarters) today along with their ER. This should do well tomorrow.
Ah, I see your point now sorry for any confusion on my part, FUNMAN. His resume does look impressive. Still, I’m not sure how critical the CFO position will be to the success of this company. They will live or die on getting profitable deals done same as before.
I guess my line of thinking is the timing makes no sense. If this is something shady, why force him out a few days before the conference call that he will likely be a part of?
Would be curious to hear more about Hexo myself. Don’t think they ever wrote off the AR so that could still carry a positive or negative surprise.
The CFO will presumably be on the call on Monday with him not resigning until end of November. If there are serious concerns it’ll get asked in the Q&A I would think. This could be something or could be nothing imo — I won’t be losing too much sleep over it though.
Price action makes no sense here. Seems like it just follows the sector or else performs worse. I may be adding more again soon at this rate.
Huge company + joint press conference makes this a lot more interesting than their recent deals. I probably won’t be able to listen so I appreciate anyone who can provide updates or a recap.
This could be huge. I added some more around .70
Like what I see so far today. The bid is stacked against a thin ask, so hopefully we see some fireworks this afternoon and into close.